期刊文献+

组织芯片和免疫组化技术在子宫内膜腺癌诊断的应用 被引量:1

Application of Tissue Microarray and Immunohistochemistry Technique to the Diagnosis of Endometrial Cancer
暂未订购
导出
摘要 目的评价组织芯片和免疫组化技术在子宫内膜腺癌诊断中的应用价值。方法使用组织芯片和免疫组化技术,观察60例子宫内膜腺癌和30例正常子宫内膜的P16、PTEN、E-cadherin和CtBP1表达情况。结果P16、PTEN、E-cadherin在子宫内膜癌的阳性率显著高于正常子宫内膜(P<0.05),而CtBP1的表达差异无统计学意义(P>0.05);4个免疫组化指标在不同分化癌细胞的表达差异均无统计学意义(P>0.05)。结论P16、PTEN和E-cadherin与子宫内膜腺癌有关,对于病理诊断有参考价值。使用组织芯片和免疫组化技术能够对批量样本进行快速检测。 Objective To evaluate the significance of the appliance of tissue microarray and immunohistochemistry technique on detecting the gene expression in endometrial cancer.Methods The expressions of P16,PTEN,E-cadherin and CtBP1 of the 60 patients with endometrial cancer(experimental group) and 30 patients with normal endometrial(control group) were observed by tissue microarray technology and immunohistochemichal methods.Results The Positive expressions of P16,PTEN and E-cadherin of the patients in the experimental group were significantly higher than those in the control group(P 0.05),while there was no difference of CtBP1 expression between the two groups(P 0.05) .Besides,there were no differences of the expressions of 4 indicators of immunohistochemistry in different cancer cell differentiation(P 0.05) .Conclusion Tissue microarray and immunohistochemistry technique could be useful and reliable in the quick diagnosis of endometrial cancer in the mass samples,which indicates that there are relationships between P16,PTEN,E-cadherin and endometrial cancer and they are of reference values for pathologic diagnosis.
出处 《广西医学》 CAS 2010年第11期1337-1339,共3页 Guangxi Medical Journal
关键词 子宫内膜腺癌 组织芯片技术 免疫组化染色 P16 PTEN E-cadherin CtBP1 Endometrial cancer Tissue microarrays Immuhistochemistry P16 PTEN E-cadherin CtBP1
  • 相关文献

参考文献8

二级参考文献65

  • 1罗淑桂,王祥珍,孙显斌.p16和nm23在宫颈癌组织中的表达及临床意义[J].中国实用妇科与产科杂志,2004,20(7):421-422. 被引量:7
  • 2贾学玲,高云荷,张煦.子宫内膜增生及内膜癌中PTEN、Ki-67蛋白的表达[J].临床与实验病理学杂志,2003,19(2):152-155. 被引量:19
  • 3林贞花,柳明沫,赵祎玮,吴群英,刘双平,金仁仙.人乳头状瘤病毒阴性的宫颈癌及其癌前病变中p16^(INK4A)蛋白表达和DNA倍体分析[J].中华病理学杂志,2006,35(7):412-416. 被引量:13
  • 4Negri G, Bellisano G, Zannoni G F, et al. p16ink4a and HPV L1 immunohistoehemistry is helpful for estimating the behavior of lowgrade dysplastie lesions of the cervix uteri [ J]. Am J Surg Pathol, 2008,32( 11 ) :1715 - 1720.
  • 5Branca M,Ciotti M, Santini D, et al. p16(INK4A) expression is related to grade of cin and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome [ J ]. Int J Gynecol Pathol, 2004,23 (4) :354 - 365.
  • 6Melsheimer P, Kaul S, Dobeck S, et al. Immunocytochemical detection of HPV high-risk type L1 capsid proteins in LSIL and HSIL as compared with detection of HPV L1 DNA [ J ]. Acta Cytol, 2003,47(2) :124 - 128.
  • 7Griesser H, Sander H, Hilfrich R, et al. Correlation of immunochemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild/moderate dysplasia[ J]. Anal Quant Cytol Histol, 2004,26(5) :241 -245.
  • 8Lee H, Lee K J, Jung C K, et al. Expression of HPV L1 capsid protein in cervical specimens with HPV infection [ J ]. Diagn Cytopathol,2008,36 ( !2 ) : 864 - 867.
  • 9Kruse A J, Skaland I, Janssen E A, et al. Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability[ J]. Int J Gynecol Pathol, 2004,23 (2) : 100 - 109.
  • 10Kurvinen K, Syrjanen K, Syrjanen S. p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions[J]. J Clin Oncol,1996,14(7) :2120 -2130.

共引文献39

同被引文献4

  • 1Baker J.Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma:A meta-analysis and systematic review of the literature[J].Gynecol Oncol,2012,125(1):512-513.
  • 2Tanaka T,Toujima S,Tanaka J.Differential sensitivity to paclitaxel-induced apoptosis and growth suppression in paclitaxel-resistant cell lines established from HEC-1 human endometrial adenocarcinoma cells[J].Int J Oncol,2012,41(5):612.
  • 3李姝君,沈湘,杨志雄,吴爱兵,唐志,黎明春,令映霞.MMP2过表达在子宫内膜腺癌的临床意义[J].南方医科大学学报,2014,34(3):423-425. 被引量:13
  • 4掌娟.免疫组化技术在子宫内膜腺癌诊断的应用分析[J].中国继续医学教育,2014,6(1):17-18. 被引量:3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部